Biorasi, LLC: Biorasi Featured in AOBiome B244 Clinical Study Report in The Lancet's eClinicalMedicine

MIAMI, FL / ACCESSWIRE / May 16, 2023 / Biorasi, a leading global full-service contract research organization (CRO), is proud to announce our inclusion in AOBiome Therapeutics' report on Phase 2b clinical

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Miami ,Florida ,United States ,Todd Krueger ,Gewinn Nur ,Biorasi Llcview ,Scientific Affairs ,Northwestern University Feinberg School Of Medicine ,Data Sciences ,Aobiome Therapeutics Inc ,Lancet Discovery Science ,Project Management ,Clinical Operations ,Peter Lio ,Northwestern University Feinberg School ,Worst Itch Numeric Rating Score ,Biorasi ,Featured ,Aobiome ,244 ,Linical ,Study ,Report ,Lancet ,Eclinicalmedicine ,